Nerai
1 known investors
Find your way into Nerai
Sign up to find every way you can get introduced to Nerai
- Your email: who you already know at Nerai, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Nerai team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Nerai is a biotechnology company developing personalized CRISPR-based genome editors through its MORPHEME platform, which combines automated directed evolution, high-throughput functional screening, and machine learning. It focuses on one-time genetic therapies for rare inherited diseases, with initial programs targeting the liver and retina.
Investors · 1
Kickfundlisted by KickfundBasel · $950K
How we know: Kickfund's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Nerai do?
- Nerai is a biotechnology company developing personalized CRISPR-based genome editors through its MORPHEME platform, which combines automated directed evolution, high-throughput functional screening, and machine learning. It focuses on one-time genetic therapies for rare inherited diseases, with initial programs targeting the liver and retina.
- Who are Nerai's investors?
- Nerai's investors include Kickfund.

